{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:09:30Z","timestamp":1790726970331,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004572","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","award":["WKJ-ZJ-26065"],"award-info":[{"award-number":["WKJ-ZJ-26065"]}],"id":[{"id":"10.13039\/501100004572","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018684","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018684","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ajpc.2026.101438","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:29:41Z","timestamp":1771504181000},"page":"101438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Liver fibrosis biomarkers as a prognostic tool beyond the defining components in cardiovascular-kidney-metabolic syndrome"],"prefix":"10.1016","volume":"26","author":[{"given":"Zhenyang","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Abramov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengzhang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2026.101438_bib0001","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101438_bib0002","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A Synopsis of the Evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the american heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101438_bib0003","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12933-024-02352-6","article-title":"Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0-3: a nationwide prospective cohort study","volume":"23","author":"Li","year":"2024","journal-title":"Cardiovasc. Diabetol"},{"key":"10.1016\/j.ajpc.2026.101438_bib0004","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12933-025-02689-6","article-title":"The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: evidence from two cohort studies","volume":"24","author":"Tan","year":"2025","journal-title":"Cardiovasc. Diabetol"},{"key":"10.1016\/j.ajpc.2026.101438_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004629","article-title":"Cardiovascular-kidney-metabolic syndrome and all-cause and cardiovascular mortality: a retrospective cohort study","volume":"22","author":"Tsai","year":"2025","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajpc.2026.101438_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103596","article-title":"Association between cardiovascular-kidney-metabolic syndrome, lifestyle, and all-cause and cause-specific mortality: a prospective cohort study","volume":"90","author":"Wang","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ajpc.2026.101438_bib0007","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1681\/ASN.0000000658","article-title":"Global burden of the key components of cardiovascular-kidney-metabolic syndrome","volume":"36","author":"Xie","year":"2025","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1016\/j.ajpc.2026.101438_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-025-01199-y","article-title":"Cardiovascular-kidney-metabolic syndrome and MASLD: integrating medical perspectives","author":"Zhou","year":"2025","journal-title":"Nat. Rev. Cardiol"},{"key":"10.1016\/j.ajpc.2026.101438_bib0009","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2026.101438_bib0010","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.125.325602","article-title":"Cardiovascular, kidney, liver, and metabolic interactions in heart failure: breaking down silos","volume":"136","author":"Lee","year":"2025","journal-title":"Circ. Res"},{"key":"10.1016\/j.ajpc.2026.101438_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/biom15020213","article-title":"From cardiovascular-kidney-metabolic syndrome to cardiovascular-renal-hepatic-metabolic syndrome: proposing an expanded framework","volume":"15","author":"Theodorakis","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.ajpc.2026.101438_bib0012","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2023.04.002","article-title":"Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease","volume":"79","author":"Kjaergaard","year":"2023","journal-title":"J. Hepatol"},{"key":"10.1016\/j.ajpc.2026.101438_bib0013","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/eurjpc\/zwab212","article-title":"Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"29","author":"Alon","year":"2022","journal-title":"Eur. J. Prev. Cardiol"},{"key":"10.1016\/j.ajpc.2026.101438_bib0014","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13855","article-title":"Liver fibrosis scores and prognosis in patients with cardiovascular diseases: A systematic review and meta-analysis","volume":"52","author":"Yan","year":"2022","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.ajpc.2026.101438_bib0015","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","article-title":"Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpc.2026.101438_bib0016","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl. J. Med"},{"key":"10.1016\/j.ajpc.2026.101438_bib0017","doi-asserted-by":"crossref","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","article-title":"Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acid. Res"},{"key":"10.1016\/j.ajpc.2026.101438_bib0018","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis","volume":"139","author":"Jafar","year":"2003","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.ajpc.2026.101438_bib0019","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/hep4.1054","article-title":"Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease","volume":"1","author":"Younossi","year":"2017","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.ajpc.2026.101438_bib0020","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol"},{"key":"10.1016\/j.ajpc.2026.101438_bib0021","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/a-1930-6658","article-title":"Shared mechanisms between cardiovascular disease and NAFLD","volume":"42","author":"Huang","year":"2022","journal-title":"Semin. Liver Dis"},{"key":"10.1016\/j.ajpc.2026.101438_bib0022","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.cgh.2019.12.026","article-title":"Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular events in a prospective study","volume":"18","author":"Baratta","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol"},{"key":"10.1016\/j.ajpc.2026.101438_bib0023","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jhep.2021.07.035","article-title":"Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States","volume":"75","author":"Kim","year":"2021","journal-title":"J. Hepatol"},{"key":"10.1016\/j.ajpc.2026.101438_bib0024","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70104","article-title":"Association of liver fibrosis scores with all-cause and cardiovascular mortality in patients with heart failure","volume":"17","author":"Guo","year":"2024","journal-title":"Clin. Transl. Sci"},{"key":"10.1016\/j.ajpc.2026.101438_bib0025","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/gutjnl-2018-317593","article-title":"Advances in non-invasive assessment of hepatic fibrosis","volume":"69","author":"Loomba","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.ajpc.2026.101438_bib0026","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.3350\/cmh.2024.0392","article-title":"Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"30","author":"Chon","year":"2024","journal-title":"Clin. Mol. Hepatol"},{"key":"10.1016\/j.ajpc.2026.101438_bib0027","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jhep.2020.03.032","article-title":"Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis","volume":"73","author":"Parisinos","year":"2020","journal-title":"J. Hepatol"},{"key":"10.1016\/j.ajpc.2026.101438_bib0028","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jhep.2021.02.034","article-title":"Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort","volume":"75","author":"Harrison","year":"2021","journal-title":"J. Hepatol"},{"key":"10.1016\/j.ajpc.2026.101438_bib0029","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/14728222.2021.1992385","article-title":"Cellular senescence in liver fibrosis: implications for age-related chronic liver diseases","volume":"25","author":"Udomsinprasert","year":"2021","journal-title":"Expert Opin. Ther Targets"},{"key":"10.1016\/j.ajpc.2026.101438_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123402","article-title":"Molecular basis of accelerated aging with immune dysfunction-mediated inflammation (inflamm-aging) in patients with systemic sclerosis","volume":"10","author":"Shen","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ajpc.2026.101438_bib0031","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1007\/s11357-023-00880-9","article-title":"Systemic inflammation and biological aging in the Health and Retirement Study","volume":"45","author":"Meier","year":"2023","journal-title":"Geroscience"},{"key":"10.1016\/j.ajpc.2026.101438_bib0032","first-page":"1397","article-title":"Delaying renal aging: metformin holds promise as a potential treatment","volume":"16","author":"Zheng","year":"2024","journal-title":"Aging Dis"},{"key":"10.1016\/j.ajpc.2026.101438_bib0033","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/s41591-024-03223-z","article-title":"Integrating liver endpoints in clinical trials of cardiovascular and kidney disease","volume":"30","author":"Zannad","year":"2024","journal-title":"Nat. Med"},{"key":"10.1016\/j.ajpc.2026.101438_bib0034","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/j.jhep.2024.12.014","article-title":"CKM: a new approach to managing metabolic comorbidities in MASLD?","volume":"82","author":"Yang","year":"2025","journal-title":"J. Hepatol"},{"key":"10.1016\/j.ajpc.2026.101438_bib0035","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ajpc.2026.101438_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.101049","article-title":"Prevalence and long-term outcomes of NAFLD and cardiovascular-kidney-metabolic health in the United States","volume":"23","author":"Liu","year":"2025","journal-title":"Am. J. Prev. Cardiol"},{"key":"10.1016\/j.ajpc.2026.101438_bib0037","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.ajpc.2026.101438_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154433","article-title":"MAFLD and risk of CKD","volume":"115","author":"Sun","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.ajpc.2026.101438_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1501494","article-title":"The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a predictive indicator of CKD risk in NAFLD patients: NHANES 2017-2020","volume":"11","author":"Fan","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.ajpc.2026.101438_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10061245","article-title":"Combined effects of chronic kidney disease and nonalcoholic fatty liver disease on the risk of cardiovascular disease in patients with diabetes","volume":"10","author":"Chung","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ajpc.2026.101438_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/biom12010105","article-title":"Liver stiffness, albuminuria and chronic kidney disease in patients with NAFLD: a systematic review and meta-analysis","volume":"12","author":"Ciardullo","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ajpc.2026.101438_bib0042","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gutjnl-2020-323082","article-title":"Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ajpc.2026.101438_bib0043","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ncpendmet0190","article-title":"Mechanisms of disease: hepatic steatosis in type 2 diabetes\u2013pathogenesis and clinical relevance","volume":"2","author":"Roden","year":"2006","journal-title":"Nat. Clin. Pr. Endocrinol Metab"},{"key":"10.1016\/j.ajpc.2026.101438_bib0044","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4093\/dmj.2023.0350","article-title":"Insulin resistance, non-alcoholic fatty liver disease and type 2 diabetes mellitus: clinical and experimental perspective","volume":"48","author":"Jung","year":"2024","journal-title":"Diabetes Metab. J"},{"key":"10.1016\/j.ajpc.2026.101438_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154766","article-title":"Insulin resistance, cardiovascular stiffening and cardiovascular disease","volume":"119","author":"Hill","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.ajpc.2026.101438_bib0046","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12933-022-01729-9","article-title":"Insulin resistance mediates obesity-related risk of cardiovascular disease: a prospective cohort study","volume":"21","author":"Tian","year":"2022","journal-title":"Cardiovasc. Diabetol"},{"key":"10.1016\/j.ajpc.2026.101438_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1483468","article-title":"Association between various insulin resistance indices and cardiovascular disease in middle-aged and elderly individuals: evidence from two prospectives nationwide cohort surveys","volume":"15","author":"Li","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajpc.2026.101438_bib0048","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13098-024-01408-7","article-title":"The U-shape relationship between insulin resistance-related indexes and chronic kidney disease: a retrospective cohort study from National Health and Nutrition Examination Survey 2007-2016","volume":"16","author":"Shen","year":"2024","journal-title":"Diabetol. Metab. Syndr"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726000322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726000322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T07:41:01Z","timestamp":1779694861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667726000322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":48,"alternative-id":["S2666667726000322"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101438","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver fibrosis biomarkers as a prognostic tool beyond the defining components in cardiovascular-kidney-metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101438"}}